Casper vs AbbVie

About

Casper is a direct-to-consumer sleep products company that pioneered the "bed-in-a-box" category — shipping compressed foam mattresses in compact boxes directly to consumers' homes, disrupting the traditional mattress retail model where consumers visited showrooms to buy from a limited selection at high markups. Founded in 2014 in New York by Philip Krim, Neil Parikh, T. Luke Sherwin, Jeff Chapin, and Gabriel Flatow, Casper went public in 2020 (NYSE: CSPR) but was taken private again in 2022 by Durational Capital Management after the stock underperformed.\n\nCasper's product line includes multiple mattress tiers (The Casper, Wave Hybrid, Nova Hybrid) across different price points, pillows, sheets, duvets, a dog mattress, and sleep accessories. The 100-night risk-free trial (free returns if unsatisfied) was a key innovation that reduced the risk of buying a mattress online without trying it — addressing the primary consumer objection to mattress e-commerce. Casper expanded into retail with showroom stores and retail partnerships (Target, retail stores) to let consumers experience products before buying online.\n\nIn 2025, Casper operates in the direct-to-consumer mattress market alongside Purple (NASDAQ: PRPL), Saatva, Nectar, and dozens of other online mattress brands that emerged after Casper proved the model in 2014-2016. The DTC mattress category became intensely competitive as the bed-in-a-box model was quickly replicated, compressing margins and raising customer acquisition costs. Private ownership under Durational Capital provides Casper with the ability to focus on sustainable unit economics without public market quarterly pressure. The 2025 strategy focuses on maintaining brand premium through product quality differentiation, growing the Sleep Shop retail presence, and building customer loyalty through the sleep ecosystem (mattress + accessories) rather than one-time mattress purchases.